Physician profile

Natasha Bhalla

Oral and Maxillofacial Surgery · Woburn, MA

NPI 1801272901

$2,171.69

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$317.65
Gift$86.94

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Stryker Corporation $595.86 2019-2022
Depuy Synthes Sales INC. $336.12 2019-2022
Axogen $270.48 2021-2023 Avance Nerve Graft
Ivoclar Vivadent, INC. $269.75 2024 Cervitec
Integra Lifesciences Corporation $223.95 2022
Geistlich Pharma, North America, INC. $184.78 2019
Kci USA, INC. $180.84 2021
Ultradent Products INC $86.94 2024 Opalescence
Orapharma, A Division of Bausch Health US, LLC $22.97 2024 Ossix Plus

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Natasha Bhalla

$2,171.69

in general payments reported 2019-2025

Years
2019-2024
Top company
Stryker Corporation

https://glasscript.com/doctor/7211381/natasha-bhalla

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.